Empashield-L 25/5 Tablet

Empagliflozin works by selectively blocking a protein in the kidneys called the sodium-glucose co-transporter 2 (SGLT2). This protein is responsible for reabsorbing glucose from the urine back into the bloodstream. Empagliflozin inhibits this protein, causing the excess glucose to be eliminated through the urine, which helps lower blood sugar levels in people with type 2 diabetes. Additionally, this process leads to mild salt and water loss, helping to reduce the workload on the heart and protect kidney function, thereby lowering the risk of heart failure and progression of chronic kidney disease.

Insomnia (difficulty in sleeping), Fainting, Fournier's gangrene, Nausea, Increased thirst, Hypoglycemia (low blood glucose level), Nasopharyngitis (inflammation of the throat and nasal passages), Urinary tract infection, Vomiting, Constipation, Polyuria, Upper respiratory tract infection, Postural hypotension (low blood pressure), Genital fungal infection

Linagliptin is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels.

Nasopharyngitis (inflammation of the throat and nasal passages), Cough, Constipation, Pancreatic inflammation, Hypoglycemia (low blood glucose level), Rash, Vomiting, Diarrhea, Joint pain, Itching, Bullous pemphigoid